Skip to main content
. 2024 Jan 3;49(6):e20230227. doi: 10.36416/1806-3756/e20230227

Table 2. Ventilatory and biochemical parameters of patients with COVID-19 before and during ELMO use, by treatment outcome.a .

Parameter Failure group p Success group p
(n = 22) (n = 28)
Before ELMO use During ELMO use Before ELMO use During ELMO use
Sao2, % 92.5 ± 4.9 95.9 ± 2.5 0.001 93.7 ± 3.8 96.2 ± 2.4 0.010
pH 7.45 ± 0.04 7.44 ± 0.04 0.567 7.43 ± 0.07 7.43 ± 0.04 0.908
Pao2,mmHg 81.6 ± 31.4 104.8 ± 41.1 0.067 85.5 ± 30.8 128.1 ± 47.8 < 0.001
Paco2, mmHg 35.8 ± 7.2 35.5 ± 3.1 0.694 38.2 ± 11.2 37.6 ± 5.6 0.797
HCO3, mmol/L 24.3 ± 2.2 24.3 ± 2.5 0.651 25.2 ± 2.1 25.2 ± 2.2 0.48
BE, mmol/L 0.2 [−1.1 to 2.5] 0.6 [−0.5 to 3.6] 0.173 1.25 [0.05-2.13] 0.9 [0.0-2.7] 0.948
Lactate, mmol/L 1.85 [1.13-2.52] 1.6 [1.0-2.12] 0.511 1.48 [1.09-2.13] 1.66 [1.23-2.00] 0.518
Pao2/Fio2 126.7 ± 49.1 177.08 ± 83.27 0.024 125.9 ± 37.4 217.56 ± 113.13 < 0.001
a

Values expressed as mean ± SD or median [IQR]. HCO3: bicarbonate; and BE: base excess.